Cite

HARVARD Citation

    Richez, V. et al. (n.d.). Carfilzomib weekly 20/56 mg/m2, lenalidomide and dexamethasone for early relapsed refractory multiple myeloma. American journal of hematology. 94 (1), pp. E17-E20. [Online]. 
  
Back to record